IMPACT Therapeutics ("IMPACT"), a biopharmaceutical company focusing on the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality, is pleased to announce ...

Camarria Williams, a Chicago middle schooler, has uncovered a cancer-fighting compound in goose poop. The droppings that the ...

Eterna Therapeutics, Inc. (ERNA) announced Tuesday positive results from a preclinical study on the company's lead cell therapy ...

By successfully turning the “cold” tumor into “hot” – transforming the tumor microenvironment from having low immune activity to an active immune environment – ERNA-101 may not only lead to improved ...

A middle school student in Chicago made headlines by uncovering a remarkable medical breakthrough hidden in a surprising ...

EXCLUSIVE: When Kevin Davies saw volunteers swabbing concert goers for the stem cell register, he never dreamed he'd be a ...

Cells is under clinical development by ICamuno Biotherapeutics and currently in Phase I for Ovarian Cancer. According to GlobalData, Phase I drugs for Ovarian Cancer have a 73% phase transition ...

SY-001 is under clinical development by CellOrigin Technology (Hangzhou) and currently in Phase I for Pancreatic Cancer.

When Lizzie Spear noticed the bags under her eyes, she never imagined it would lead to a life-changing diagnosis and require ...

Despite recent therapeutic breakthroughs, cancer patients continue to face high recurrence and mortality rates due to treatment resistance. Cancer stem cells (CSCs), a subpopulation with self-renewal ...

Each measurement was performed 3 times. The human ovarian carcinoma cell line HEYA8 was generously provided by Dr J Liu from MD Anderson Cancer Center, Houston, TX, while SKOV3 cells were acquired ...

Korean researchers have developed a technology that treats colon cancer by converting cancer cells into a state resembling normal colon cells. Listen to Story Researchers in South Korea have developed ...